Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD) Q4 2020 earnings call dated Feb. 17, 2021 Corporate Participants: Meredith Kaya — Vice President, Investor Relations and Corporate Communications Mark Mallon — Chief Executive Officer Thomas McCourt — President Gina Consylman — Senior Vice President, Chief Financial Officer Michael Shetzline — Chief Medical Officer, Senior Vice President and Head of Drug Development Analysts: Mark Connolly — Credit Suisse — Analyst Eric...
To read the full story, subscribe to AlphaStreet's FREE membership.
Why FREE membership?
- It allows you to highlight any particular content/data in the earnings call transcripts, add your insights, and share it seamlessly within your community
- You can access preliminary earnings call transcripts during the the call, that is, in real time!
- Track your favorite stocks and receive customized email alerts in your Inbox to keep you updated about any information regarding them
Already a member? Sign In now